ARCHIVES

Wyden Compared Taxol To AZT; But Experts Note Lack Of Patent

This article is from The Cancer Letter archive.

Vol. 17 No. 32 | August 9, 1991

Download PDF Visit The Full Archive

Related Articles

NCI To Fund 29% Of Grants In 1990, With Budget Cuts

February 17, 1989

Zofran Label Change Includes Warnings of QT Prolongation

September 30, 2011

NCI director apologizes to cancer centers for inaction on working group report.

October 31, 2003

Amid Protests Over Grant Paylines, NCI’s Niederhuber Tells Scientists To Get “Leaner And Better”.

April 7, 2006

Governors Hear Pitch For State Cancer Control Increased Effort

August 3, 1979

Guest Editorial: As Sequestration Becomes More Likely, Health Groups Must Make Themselves Heard

February 22, 2013